Over the past decade, drug-eluting stents (DES) have greatly transformed the field of interventional cardiology. Generally, three components are included in a DES system: a metal stent platform, a ...

A drug-eluting resorbable scaffold was superior to angioplasty in treating infrapopliteal artery disease and chronic limb-threating ischemia and was noninferior for safety in the LIFE-BTK trial.

Compared with plain old balloon angioplasty (POBA), drug-eluting stent and drug-coated balloon (DCB) technologies do not improve amputation-free survival in patients with chronic limb-threatening ...

SAN FRANCISCO — The first-time application of a triple-drug, site-specific antithrombotic therapy on a stent platform was safe and effective for managing thrombotic and bleeding risk after PCI ...

Confirming previously presented earlier results, a paclitaxel-coated balloon was superior to conventional balloon angioplasty for treatment of coronary in-stent restenosis. As Healio previously ...

Drug-eluting resorbable scaffolds have potential advantages that may make them suitable for the treatment of infrapopliteal artery disease, and observational studies have shown promising results ...

The full analysis set population consisted of 5,966 patients (no-aspirin group: 2,984 patients; DAPT group: 2,982 patients). The average age was 71.6 years and 23.4% were women.

PARIS, France—It’s not a stent in a traditional sense, nor a scaffold that completely disappears over time, but a new device—one that “unchains” itself over time—has cleared an early hurdle by proving ...